The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Compass Therapeutics Inc shares valued at $5,678,571 were purchased by OrbiMed Genesis Master Fund, L on Apr 09 ’25. At $1.59 per share, OrbiMed Genesis Master Fund, L acquired 3,571,428 shares.
Also, The Biotech Growth Trust PLC purchased 3,571,428 shares, netting a total of over 5,678,571 in proceeds.
Before that, Anderman Jonathan had added 20,000 shares to its account. In a trade valued at $30,800, the Gen Counsel & Corporate Sec bought Compass Therapeutics Inc shares for $1.54 each. Upon closing the transaction, the insider’s holdings increased to 20,000 shares, worth approximately $36750.0.
As published in a research note from Leerink Partners on April 02, 2025, Compass Therapeutics Inc [CMPX] has been rated up from a Market perform to an Outperform and the price target has been revised to $6. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in late February. As of February 19, 2025, Piper Sandler has initiated its “an Overweight” rating for CMPX. Earlier on December 23, 2024, D. Boral Capital initiated its rating. Their recommendation was “a Buy” for CMPX stock.
Analyzing CMPX Stock Performance
During the last five days, there has been a surge of approximately 3.55%. Over the course of the year, Compass Therapeutics Inc shares have jumped approximately 20.69%. Shares of the company reached a 52-week high of $4.0800 on 02/11/25 and a 52-week low of $1.3300 on 04/01/25. A 50-day SMA is recorded $2.6670, while a 200-day SMA reached $1.8146.
Support And Resistance Levels for Compass Therapeutics Inc (CMPX)
According to the 24-hour chart, there is a support level at 1.5467, which, if violated, would cause prices to drop to 1.3433. In the upper region, resistance lies at 1.9267. The next price resistance is at 2.1033. RSI (Relative Strength Index) is 39.39 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.2762, which suggests the price will decrease in the coming days. Percent R is at 61.82%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
